Patents by Inventor Paul Jeffrey SANDERS

Paul Jeffrey SANDERS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Spray-dried thrombin and methods of using and making spray-dried thrombin
    Patent number: 11583610
    Abstract: Spray-dried thrombin materials obtained from feedstock solutions comprising less than 5% by weight albumin and excluding trehalose or other excipients as well as methods of manufacturing the thrombin materials and methods of treating bleeding wounds are disclosed. The methods of use include applying reconstituted spray-dried thrombin topically to a bleeding site, optionally in conjunction with gelatin.
    Type: Grant
    Filed: December 20, 2018
    Date of Patent: February 21, 2023
    Assignees: Baxter International Inc., Baxter Healthcare SA
    Inventors: Alexander Wesley Scott, Paul Jeffrey Sanders, Alyssa Sanders, Adam Christopher Mercer
  • SPRAY-DRIED THROMBIN AND METHODS OF USING AND MAKING SPRAY-DRIED THROMBIN
    Publication number: 20210379240
    Abstract: Spray-dried thrombin materials obtained from feedstock solutions comprising less than 5% by weight albumin and excluding trehalose or other excipients as well as methods of manufacturing the thrombin materials and methods of treating bleeding wounds are disclosed. The methods of use include applying reconstituted spray-dried thrombin topically to a bleeding site, optionally in conjunction with gelatin.
    Type: Application
    Filed: December 20, 2018
    Publication date: December 9, 2021
    Inventors: Alexander Wesley SCOTT, Paul Jeffrey SANDERS, Alyssa SANDERS, Adam Christopher MERCER
  • DEVICE FOR DELIVERY OF POWDERED HEMOSTATIC AGENTS
    Publication number: 20200016292
    Abstract: The disclosure provides a multilayered hemostatic device including a first layer including carboxymethyl cellulose, a second layer including a powdered hemostatic agent provided on the first layer, and a third layer including at least one of gauze, oxidized cellulose, or collagen provided on the second layer, wherein the first layer and the third layer encapsulate the second layer and the hemostatic agent comprises one of fibrinogen, thrombin, fibrin monomers, or the combination of thrombin and gelatin.
    Type: Application
    Filed: March 7, 2018
    Publication date: January 16, 2020
    Inventors: Russel L. HOLSCHER, Paul Jeffrey SANDERS, Timothy Michael FULGHUM, John Joseph Anthony BARRY